Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cortexyme Inc (NQ: CRTX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cortexyme Inc < Previous 1 2 3 4 5 Next > Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression October 26, 2021 From Cortexyme, Inc. Via Business Wire Why This Alzheimer's Study Missed, But That's Not Necessarily A Bad Thing For Cortexyme October 26, 2021 Cortexyme said Tuesday its experimental Alzheimer's drug might work in some patients. Via Investor's Business Daily Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market October 21, 2021 Cortexyme is testing a twice-day pill to treat Alzheimer's disease. Via Investor's Business Daily Cramer Likes Azek And SoFi, But Said Owning This Stock Could Be Dreadful October 08, 2021 On CNBC's "Mad Money Light... Via Benzinga Before The Bubble Bursts August 14, 2021 Maybe some good can come out of the market bubble -- for Alzheimer's patients, and for investors in Cortexyme. Via Talk Markets Analyzing Cortexyme's Unusual Options Activity August 09, 2021 On Monday, shares of Cortexyme (NASDAQ:CRTX) saw unusual ... Via Benzinga 51 Biggest Movers From Friday October 18, 2021 Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it... Via Benzinga Cortexyme to Present Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer’s Disease at CTAD 2021 September 27, 2021 From Cortexyme, Inc. Via Business Wire Cortexyme Expands Proprietary Development Pipeline with Initiation of Phase 1 Clinical Trial of COR588 September 08, 2021 From Cortexyme, Inc. Via Business Wire Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th September 07, 2021 From Cortexyme, Inc. Via Business Wire 10 Biggest Price Target Changes For Thursday August 26, 2021 Keybanc raised the price target for Intuit Inc. (NASDAQ: Via Benzinga Cortexyme Presents New Data Demonstrating Evidence of P. Gingivalis Infection of the Central Nervous System in Alzheimer’s Disease at Annual Biomarkers for Alzheimer’s Disease Summit August 25, 2021 From Cortexyme, Inc. Via Business Wire Cortexyme to Present at Annual Biomarkers for Alzheimer’s Disease Summit August 18, 2021 From Cortexyme, Inc. Via Business Wire Cortexyme: Shifting The Odds In Your Favor So Your Best Case Outcome Is Three Times Higher Than Your Worst Case August 16, 2021 Screen capture via Cortexyme animation. A Bigger Bubble Than The Late '90s Phoenix Capital Research offered an interesting comparison of the current stock market to that... Via Benzinga The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... Via Talk Markets Topics Initial Public Offering Exposures Securities Market The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow August 15, 2021 Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Tuesday's After-Market Session August 10, 2021 Gainers CohBar (NASDAQ:CWBR) shares incr... Via Benzinga The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety 85 Biggest Movers From Yesterday August 11, 2021 Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... Via Benzinga Stocks That Hit 52-Week Highs On Tuesday August 10, 2021 Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (... Via Benzinga The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... Via Benzinga Exposures COVID-19 68 Biggest Movers From Yesterday August 10, 2021 Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a... Via Benzinga Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher August 09, 2021 Toward the end of trading Monday, the Dow traded down 0.17% to 35,150.02 while the NASDAQ rose 0.26% to 14,874.23. The S&P also rose, gaining 0.01% to 4,436.62. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session August 09, 2021 Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 33.66% to $4.3 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 87.6... Via Benzinga Mid-Day Market Update: Crude Oil Down 2.5%; Golden Nugget Online Gaming Shares Jump August 09, 2021 Midway through trading Monday, the Dow traded down 0.23% to 35,126.98 while the NASDAQ rose 0.20% to 14,866.01. The S&P also fell, dropping 0.08% to 4,432.96. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Cortexyme Provides Business Update and Reports Second Quarter 2021 Results August 09, 2021 From Cortexyme, Inc. Via Business Wire Cortexyme to Present at Canaccord Genuity' s 41st Annual Growth Conference on August 11th August 04, 2021 From Cortexyme, Inc. Via Business Wire The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO August 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Cortexyme Presents Data Linking P. Gingivalis to Elevated Levels of Phospho-tau217 Reinforcing Evidence of Pathogen as Causative Agent of Alzheimer’s Disease at AAIC 2021 July 26, 2021 From Cortexyme, Inc. Via Business Wire The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.